Vaclav Janovec, Jan Hodek, Kamila Clarova, Tomas Hofman, Pavel Dostalik, et al.. Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes.
Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.12767.
⟨10.1038/s41598-020-69614-7⟩.
⟨inserm-02941953⟩